It has become well-acknowledged that cancer patients exhibit higher levels of NET biomarkers compared with non-cancer patients 82 and cancer-associated NETs promote platelet capturing and increase tissue factor (TF) activity, thereby leading to CAT 74-76, 83. Here, F3 is linked to cancer.